The introduction of 750mcg teriparatide injection in Australia has experienced modest uptake. Currently, it’s largely offered for patients with severe osteoporosis where other options have failed . Access this more potent formulation is restricted due to specialist prescription requirements and limited hospital supply . While a few dispensaries m